MentionFox
Home › funding signals › Pearl Diagnostics, Inc.
Form D · on the record

Pearl Diagnostics — $11.15M Form D filing, April 2026

Pearl Diagnostics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-04-21.

Pearl Diagnostics, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 21, 2026. The filing reports $11.15M sold. Its industry group is Biotechnology. It names Kieren Marr (Executive Officer, Director), Brad Spellberg (Director), John Cammack (Director) (SEC Form D, April 21, 2026).

In its own words: “Pearl Diagnostics is changing the way clinicians diagnose lung infections.” (pearldx.com, checked November 8, 2026)

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

5 more Biotechnology raises in Maryland within 90 days ↓

Is this your company?

Key facts

Run the free check on Pearl Diagnostics, Inc. →

Sell to companies like Pearl Diagnostics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Pearl Diagnostics, Inc.

New Form D on file · 2026-04-21 · the record

$11.15M
raise on the record
D
filing
21
investors in
MARYLAND
based
Open the record →

What the record says

FilingForm D
Filed2026-04-21
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2022
BasedBALTIMORE, MARYLAND
CIK1922830
Accession0001922830-26-000003

Pitching, partnering or investing alongside them? See who really runs and owns Pearl Diagnostics, Inc.

Watch Pearl Diagnostics, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on the people and the money behind Pearl Diagnostics, Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Maryland, filed within 90 days of this one, largest first.

What do you want to do with Pearl Diagnostics, Inc.?

Get the full cited report on Pearl Diagnostics, Inc.

What the filing shows about Pearl Diagnostics, Inc.

  • The filing reports $500K of the proceeds going to the company's own executives, directors or promoters.
  • 21 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Pearl Diagnostics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Pearl Diagnostics, Inc.'s address as 1812 Ashland Avenue, Suite G32, Baltimore, MD 21205.

What the filing says

  • Offered: $11,150,000. Sold: $11,150,000. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 21 had already invested. (filing)
  • Date of first sale: March 19, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16, payments to executive officers, directors or promoters: $500,000 of the proceeds is used or proposed to be used for such payments (the filing marks this amount as an estimate). The filing gives no explanation. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Pearl Diagnostics, Inc. See pricing

Is Pearl Diagnostics, Inc. a real, registered company?

Pearl Diagnostics, Inc. is a registered filer with the SEC (CIK 1922830) and has filed since 2026-04-21. 1 filing is on record, the latest on 2026-04-21.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Pearl Diagnostics, Inc.?

Pearl Diagnostics, Inc.'s Form D of 2026-04-21 names Kieren Marr, Brad Spellberg, John Cammack and 1 more as its officers, directors or promoters.

How much has Pearl Diagnostics, Inc. raised?

Its new offerings report $11.15M sold across 1 offering, as its own filings state.

Biotechnology · by week
This raise, $11.15M, filed week of Apr 20

Trailing twelve months. 764 filings in Biotechnology, totalled by week. The dot is this raise, $11.15M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Pearl Diagnostics, Inc.?

What the filing shows about Pearl Diagnostics, Inc.

  • The filing reports $500K of the proceeds going to the company's own executives, directors or promoters.
  • 21 investors had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Pearl Diagnostics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Pearl Diagnostics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Pearl Diagnostics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Pearl Diagnostics, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

More on Pearl Diagnostics, Inc.

On these lists: Biotech raises in Baltimore

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Pearl Diagnostics, Inc.: Raised $11.15M, Form D filed 2026-04-21
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/pearl-diagnostics-inc-form-d-26000003
Last updated 2026-10-29
Primary record: SEC filing 1 · SEC filing 2
Pearl Diagnostics raised $11.15M — SEC Form D filing, April 2026. MentionFox, 2026-10-29. https://mentionfox.com/funding/pearl-diagnostics-inc-form-d-26000003